Vivo Opportunity Fund Holdings, L.P.
CIK 1930214 · last filed 2024-05-01
Vivo Opportunity Fund Holdings, L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 1 company since 2023. The most recent filing, for UNCY, was dated Jul 1, 2026. Across all open-market trades the lifetime net is −$103.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
6
-$103.40M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC (SLNO) Delisted | 10%+ Owner | 7,668,093 | $53.01 | $406.49M | -$103.40M | 3 | 2024-05-01 |
Recent Filings
6 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-01 | UNCY | Notice (144) | −1,789,916 | -$9.45M | EDGAR |
| 2024-05-01 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Sell (S) | −2,202,484 | -$103.40M | EDGAR |
| 2024-04-03 | TERN | Notice (144) | −136,258 | -$817.5K | EDGAR |
| 2024-04-01 | TERN | Notice (144) | −221,095 | -$1.57M | EDGAR |
| 2023-10-04 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Exer (X) | +10,430,000 | $26.07M | EDGAR |
| 2023-09-28 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Exer (X) | +6,406,186 | $11.21M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.